Company Overview
Company Name
Progentec Diagnostics
Address
755 Research Parkway, Suite #100, Oklahoma City, OK, 73104, United States
Website
progentec.comApprox. Annual Revenue
$7.2M
Employees
40
Established
2014
Locations
3
About Progentec Diagnostics
Progentec Diagnostics, Inc. is a company based in Oklahoma City, OK, United States. The company focuses on developing proactive care solutions for autoimmune diseases such as systemic lupus erythematosus and multiple sclerosis, utilizing proteomics and digital health technologies.
Progentec Diagnostics locations
3 Google Business Profile listings.
| Location | Google category | Reviews | Status |
|---|---|---|---|
| 755 Research Parkway, Suite #100, Oklahoma City, OKprimary | — | — | — |
| 655 Research Pkwy Ste 538, Oklahoma City, OK | — | — | Claimed |
| 100 Park Ave, Ste 700, Oklahoma, OK | — | — | — |
More Companies in Oklahoma
Browse all companies in Oklahoma →
Frequently Asked Questions about Progentec Diagnostics
Advertising Pixels
- Facebook Ad Pixel
- LinkedIn Ad Pixel
Categories
Technologies Used
'%20fill='%23000000'%3e%3cg%20id='icons'%20transform='translate(56.000000,%20160.000000)'%3e%3cpath%20d='M102.8695,7446.25504%20C101.3625,7444.73916%2098.9185,7444.73916%2097.4115,7446.25504%20L91.2705,7452.43224%20C90.8935,7452.81045%2090.8935,7453.42505%2091.2705,7453.80428%20C91.6475,7454.1835%2092.2585,7454.1835%2092.6355,7453.80428%20L98.7755,7447.62809%20C99.5285,7446.86964%20100.7515,7446.86964%20101.5045,7447.62809%20C102.2585,7448.38552%20102.2585,7449.61473%20101.5045,7450.37317%20L95.4825,7456.43066%20C96.2355,7457.1881%2097.4575,7457.1881%2098.2115,7456.43066%20L102.8695,7451.74521%20C104.3765,7450.22933%20104.3765,7447.77092%20102.8695,7446.25504%20M100.8225,7448.31411%20C100.4455,7447.93488%2099.8345,7447.93488%2099.4575,7448.31411%20L93.3175,7454.49029%20C92.5635,7455.24874%2091.3415,7455.24874%2090.5885,7454.49029%20C90.2115,7454.11107%2089.6005,7454.11107%2089.2235,7454.49029%20C88.8465,7454.86952%2088.8465,7455.48412%2089.2235,7455.86233%20C90.7305,7457.37922%2093.1745,7457.37922%2094.6825,7455.86233%20L100.8225,7449.68615%20C101.1995,7449.30793%20101.1995,7448.69232%20100.8225,7448.31411%20M98.7755,7442.13691%20C97.2685,7440.62103%2094.8245,7440.62103%2093.3175,7442.13691%20L87.1765,7448.31411%20C86.8005,7448.69232%2086.8005,7449.30793%2087.1765,7449.68615%20C87.5535,7450.06537%2088.1645,7450.06537%2088.5415,7449.68615%20L94.6825,7443.50996%20C95.4355,7442.75151%2096.6575,7442.75151%2097.4105,7443.50996%20C97.7875,7443.88918%2098.3985,7443.88918%2098.7755,7443.50996%20C99.1525,7443.13073%2099.1525,7442.51613%2098.7755,7442.13691%20M96.7285,7444.19598%20C96.3515,7443.81675%2095.7405,7443.81675%2095.3645,7444.19598%20L89.2235,7450.37317%20C88.4695,7451.13061%2087.2485,7451.13061%2086.4945,7450.37317%20C85.7405,7449.61473%2085.7405,7448.38552%2086.4945,7447.62708%20L92.5175,7441.56959%20C91.7635,7440.81114%2090.5415,7440.81114%2089.7875,7441.56959%20L85.1295,7446.25504%20C83.6235,7447.77092%2083.6235,7450.22933%2085.1295,7451.74521%20C86.6375,7453.2621%2089.0805,7453.2621%2090.5885,7451.74521%20L96.7285,7445.56902%20C97.1055,7445.1898%2097.1055,7444.5752%2096.7285,7444.19598'%20id='squarespace-[%23132]'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
%20--%3e%3csvg%20version='1.1'%20id='st_x5F_cc_x5F_app_x5F_RGB.svg'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%20240.0004%20234.0004'%20style='enable-background:new%200%200%20240.0004%20234.0004;'%20xml:space='preserve'%3e%3cstyle%20type='text/css'%3e%20.st0{fill:url(%23SVGID_1_);}%20.st1{fill:%23FFFFFF;}%20%3c/style%3e%3clinearGradient%20id='SVGID_1_'%20gradientUnits='userSpaceOnUse'%20x1='119.9997'%20y1='234.0002'%20x2='119.9997'%20y2='0.0002'%3e%3cstop%20offset='0'%20style='stop-color:%23201F21'/%3e%3cstop%20offset='1'%20style='stop-color:%23313131'/%3e%3c/linearGradient%3e%3crect%20x='-0.0003'%20y='0.0002'%20class='st0'%20width='240'%20height='234'/%3e%3cg%3e%3cpath%20class='st1'%20d='M132.24969,97.95853c-5.60328,18.77988-10.28088,36.91208-15.88416,54.63138%20c-3.18081,9.99579-6.66385,19.53729-11.05544,25.59485c-4.84678,6.81497-13.93402,13.32771-24.83743,13.32771%20c-7.72443,0-15.29683-3.63509-15.29683-11.66174c0-4.99789,5.14901-9.69264,9.23837-9.69264%20c2.42339,0,3.63508,1.36282,4.24046,2.42339c3.7862,6.81497,7.42128,10.75229,9.08724,10.75229s3.02878-2.27135,5.7544-12.1151%20l19.82331-73.26013H99.08337c-1.06058-3.18081,0.45427-7.11812,2.27135-7.87554h14.23625%20c2.72562-8.7841,5.92356-17.60862,10.46719-25.63529c6.81497-12.26713,17.7193-21.95976,32.71205-21.95976%20c11.3586,0,16.05333,5.45216,16.05333,12.41917c-0.15111,7.42036-6.66293,11.20656-9.69263,11.20656%20c-2.42247,0-3.63416-1.81709-4.39159-4.39159c-2.57451-9.69263-5.90643-12.57029-7.87555-12.57029%20c-1.9682,0-4.99789,3.63416-8.3289,11.20656c-4.3925,9.54151-7.28729,19.72977-10.01291,29.72464h17.26501%20c1.05966,2.12023,0.15112,6.66385-2.42339,7.87554H132.24969z'/%3e%3c/g%3e%3c/svg%3e)
Social Profiles
Key Decision Makers
Jessica Crawley Clinical Research Coordinator